다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Cell, v.86 no.4, 1996년, pp.577 - 587
Mohammadi, Moosa (Department of Pharmacology, New York University Medical Center, New York, New York 10016, USA) , Schlessinger, Joseph (Department of Pharmacology, New York University Medical Center, New York, New York 10016, USA) , Hubbard, Stevan R (Department of Pharmacology, New York University Medical Center, New York, New York 10016, USA)
AI-Helper
AbstractThe crystal structure of the tyrosine kinase domain of fibroblast growth factor receptor 1 (FGFR1K) has been determined in its unliganded form to 2.0 Å resolution and in complex with an ATP analog to 2.3 Å resolution. Several features distinguish the structure of FGFR1K from th...
Adv. Cancer Res. Basilico 59 115 1992 10.1016/S0065-230X(08)60305-X The FGF family of growth factors and oncogenes
Nature Genet. Bellus 10 357 1995 10.1038/ng0795-357 A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia
EMBO J. Bossemeyer 12 849 1993 10.1002/j.1460-2075.1993.tb05725.x Phosphotransferase and substrate binding mechanism of the cAMP-dependent protein kinase catalytic subunit from porcine heart as deduced from the 2.0 A structure of the complex with Mn2+ adenylyl imidodiphosphate and inhibitor peptide PKI(5-24)
Brunger 1992 X-PLOR
Cell Cantley 64 281 1991 10.1016/0092-8674(91)90639-G Oncogenes and signal transduction
J. Appl. Cryst. Carson 24 958 1991 10.1107/S0021889891007240 Ribbons 2.0
Joint Cowtan 31 34 1994
elegans hermaphrodites. Cell DeVore 83 611 1995 10.1016/0092-8674(95)90101-9 An FGF receptor signaling pathway is required for the normal cell migrations of the sex myoblasts in C
Cell Ellis 45 721 1986 10.1016/0092-8674(86)90786-5 Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose
J. Mol. Graphics Evans 11 134 1993 10.1016/0263-7855(93)87009-T SETOR
Acta Cryst. Hendrickson A35 158 1979 10.1107/S0567739479000279 Transformations to optimize the superposition of similar structures
Nature. Hubbard 372 746 1994 10.1038/372746a0 Crystal structure of the tyrosine kinase domain of the human insulin receptor
J. Biol. Chem. Janin 265 16027 1990 10.1016/S0021-9258(17)46181-3 The structure of protein-protein recognition sites
Biochem. Biophys. Acta Jaye 1135 185 1992 10.1016/0167-4889(92)90136-Y Fibroblast growth factor receptor tyrosine kinases
Cell Johnson 85 149 1996 10.1016/S0092-8674(00)81092-2 Active and inactive protein kinases
Interactive computer graphics Jones 115 157 1985 Diffraction methods for biological macromolecules
Biopolymers Kabsch 22 2577 1983 10.1002/bip.360221211 Dictionary of protein secondary structure
Science Kavanaugh 266 1862 1994 10.1126/science.7527937 An alternative to SH2 domains for binding tyrosine-phosphorylated proteins
Genes Dev. Klambt 6 1668 1992 10.1101/gad.6.9.1668 Breathless, a Drosophila FGF receptor homolog, is essential for migration of tracheal and specific midline glial cells
Science Knighton 253 407 1991 10.1126/science.1862342 Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase
J. Appl. Crystallogr. Kraulis 24 946 1991 10.1107/S0021889891004399 MOLSCRIPT
J. Appl. Crystallogr. Laskowski 26 283 1993 10.1107/S0021889892009944 PROCHECK
Nature Mohammadi 358 681 1992 10.1038/358681a0 Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis
Mol. Cell. Biol. Mohammadi 16 977 1996 10.1128/MCB.16.3.977 Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction
Nature Genet. Naski 13 233 1996 10.1038/ng0696-233 Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia
Acta Crystallogr. Navaza A50 157 1994 10.1107/S0108767393007597 AMoRe
Proteins Nicholls 11 281 1991 10.1002/prot.340110407 Protein folding and association
Otwinowski, Z. (1991). Maximum likelihood refinement of heavy atom parameters. In Isomorphous Replacement and Anomalous Scattering, W. Wolf, P.R. Evans, and A.G.W. Leslie, eds. (Daresbury, United Kingdom: Daresbury Laboratory), pp. 80-86.
Otwinowski, Z. (1993). Oscillation data reduction program. In Proceedings of the CCP4 Study Weekend, L. Sawyer, N. Isaacs, and S. Burley, eds. (Daresbury, United Kingdom: SERC Daresbury Laboratory), pp. 56-62.
Current Biol. Pawson 3 434 1993 10.1016/0960-9822(93)90350-W SH2 and SH3 domains
Nature Peters 358 678 1992 10.1038/358678a0 Point mutation of an FGF receptor abolishes phospatidylinositol turnover and Ca2+ flux but not mitogenesis
Cell Schlessinger 83 357 1995 10.1016/0092-8674(95)90112-4 Regulation of growth factor activation by proteoglycans
Nature Genet. Tavormina 9 321 1995 10.1038/ng0395-321 Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3
Stuctural insights from the insulin receptor protein-tyrosine kinase. FASEB J. Taylor 9 1255 1995 How do protein kinases discriminate between serine/threonine and tyrosine?
Cell Ullrich 61 203 1990 10.1016/0092-8674(90)90801-K Signal transduction by receptors with tyrosine kinase activity
Nature Zhang 367 704 1994 10.1038/367704a0 Atomic structure of the MAP kinase ERK2 at 2.3 A resolution
Biochem. Zheng 32 2154 1993 10.1021/bi00060a005 Crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with MgATP and peptide inhibitor
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
저자가 APC(Article Processing Charge)를 지불한 논문에 한하여 자유로운 이용이 가능한, hybrid 저널에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.